Our October Quick Question is selected from the many open questions we received during our September 15 webinar. “Covid-Associated Coagulopathy: A Conversation about Controversies and Confusion” [click] featuring Andrew Goodwin, MD, CLIA Medical Director, University of Vermont Medical Center and Laboratory Services and Section Medical Director of the Thrombosis and Hemostasis Laboratory. In our Quick Question we repeat a participant’s question, “What inflammation assay does your laboratory use to assess SARS-CoV-2 progression?” If the answer you are thinking of doesn’t appear, please use the Comment function to provide your discussion.
Oct 1 2020
Comments (0)Quick Question Archive
No comments here.